I-Corps: Novel Catalytic Ozonation Processes for Advanced Water and Wastewater Treatment
I-Corps: Novel Catalytic Ozonation Processes for Advanced Water and Wastewater Treatment
批准号:
2309263
负责人:
Tingting Wu
金额:
$5.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-04-01 至 2024-09-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The broader impact/commercial potential of this I-Corps project is the development of plasmon-enhanced catalytic ozonation innovations to provide a cost-effective solution to the water quality challenge associated with increasing recalcitrant organic pollutants in the source water. The system adaptability of the photo-assisted catalytic ozonation process could make it a competitive treatment technology that can accommodate to both current available centralized infrastructure and emerging distributed/reuse facilities. Thus, a successful commercialization effort will help address a significant societal challenge: increasing demand for clean water under the stress of rapid population growth, shortage of fresh water sources, climate change, impaired water sources, and aging infrastructure.This I-Corps project is based on the development of an innovation of a novel catalytic ozonation process mediated by plasmonic metal catalysts for the removal of recalcitrant organic pollutants from water. Effective degradation of representative pollutants was achieved in both synthetic solutions and real environmental waters with low energy consumption and byproduct formation. The superior treatment performance together with the low material costs, mature and facile synthesis methods, and good recyclability of the catalysts, all demonstrates the great commercialization potential of plasmon-enhanced catalytic ozonation processes. It is estimated that one-third of all counties in the contiguous U.S. will face high risk of water shortage by 2050 and a market worth of $128.78 billion is forecast for water and wastewater treatment technologies by 2029. Contamination of aquatic environment with thousands of organic chemicals, which often cannot be effectively removed in conventional water and wastewater treatment, is a key water quality problem.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Plasmon-Enhanced Catalytic Ozonation for Water Treatment and Reuse
-
批准号:1606117
-
项目类别:Standard Grant
-
资助金额:$32.97万
-
财政年份:2016
-
负责人:Tingting Wu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Novel-miR-1134调控LHCGR的表达介导拟
穴青蟹卵巢发育的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:崔文晓
-
依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
-
批准号:82304677
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:边兴博
-
依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
-
批准号:82304658
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘亚
-
依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
-
批准号:32102747
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李婉雁
-
依托单位:
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:唐晓冰
-
依托单位:
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:张瑜
-
依托单位:
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
-
批准号:82070530
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:白玉作
-
依托单位:
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
-
批准号:32002421
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:修云吉
-
依托单位:
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
-
批准号:82072775
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:薛皓
-
依托单位:
miRNA/novel_167靶向抑制Dmrt1的表达在红鳍东方鲀性别分化过程中的功能研究
-
批准号:31902347
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2019
-
负责人:闫红伟
-
依托单位: